- TWD3.13bn
- TWD1.92bn
- TWD775.29m
- 73
- 41
- 60
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 921 | 841 | 931 | 899 | 775 |
Cost of Revenue | |||||
Gross Profit | 457 | 410 | 455 | 416 | 365 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 740 | 696 | 740 | 765 | 698 |
Operating Profit | 181 | 145 | 191 | 134 | 77.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 182 | 126 | 171 | 215 | 134 |
Provision for Income Taxes | |||||
Net Income After Taxes | 152 | 109 | 161 | 176 | 123 |
Net Income Before Extraordinary Items | |||||
Net Income | 152 | 109 | 161 | 176 | 123 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 152 | 109 | 161 | 176 | 123 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.76 | 1.25 | 1.82 | 1.91 | 1.36 |
Dividends per Share |